These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26873623)

  • 1. Bimatoprost solution 0·03% topical application to the eyelid margin for the treatment of eyelash hypotrichosis.
    Arujuna NR; Topham EJ; Atkinson LR; George SM; Derrick EK; Farrant PB
    Br J Dermatol; 2016 Jun; 174(6):1416-7. PubMed ID: 26873623
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy-induced eyelash loss.
    Ahluwalia GS
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S73-6. PubMed ID: 24326568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.
    Fagien S; Walt JG; Carruthers J; Cox SE; Wirta D; Weng E; Beddingfield FC
    Aesthet Surg J; 2013 Aug; 33(6):789-98. PubMed ID: 23873891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latisse (bimatoprost) for enhancement of eyelashes.
    Flaharty PM; Flaharty KK; Gorman L
    Insight; 2014; 39(3):24-6. PubMed ID: 25195339
    [No Abstract]   [Full Text] [Related]  

  • 5. Bimatoprost 0.03% solution (latisse) for eyelash enhancement.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):43-4. PubMed ID: 19478690
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth.
    Yoelin S; Walt JG; Earl M
    Dermatol Surg; 2010 May; 36(5):638-49. PubMed ID: 20384751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hypotrichosis of the eyelashes: focus on bimatoprost.
    Fagien S
    Plast Surg Nurs; 2015; 35(2):82-91. PubMed ID: 26020474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical bimatoprost for the treatment of eyebrow hypotrichosis.
    Schweiger ES; Pinchover L; Bernstein RM
    J Drugs Dermatol; 2012 Jan; 11(1):106-8. PubMed ID: 22206085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial.
    Glaser DA; Hossain P; Perkins W; Griffiths T; Ahluwalia G; Weng E; Beddingfield FC
    Br J Dermatol; 2015; 172(5):1384-94. PubMed ID: 25296533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.
    Smith S; Fagien S; Whitcup SM; Ledon F; Somogyi C; Weng E; Beddingfield FC
    J Am Acad Dermatol; 2012 May; 66(5):801-6. PubMed ID: 21899919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth.
    Cohen JL
    Dermatol Surg; 2010 Sep; 36(9):1361-71. PubMed ID: 20384750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosis.
    Yoelin SG; Fagien S; Cox SE; Davis PG; Campo A; Caulkins CA; Gallagher CJ
    Dermatol Surg; 2014 Oct; 40(10):1118-24. PubMed ID: 25229783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary: From serendipity to pilot study and then pivotal trial: bimatoprost topical for eyelash growth.
    Cohen JL
    Dermatol Surg; 2010 May; 36(5):650-1. PubMed ID: 20384740
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of hypotrichosis of the eyelashes: Focus on bimatoprost.
    Fagien S
    Clin Cosmet Investig Dermatol; 2010 Apr; 3():39-48. PubMed ID: 21437058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophy.
    Sira M; Verity DH; Malhotra R
    Aesthet Surg J; 2012 Sep; 32(7):822-4. PubMed ID: 22942109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
    Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
    J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of bimatoprost ophthalmic solution 0.03% for the treatment of eyebrow hypotrichosis: series of ten cases.
    Vergilis-Kalner IJ
    Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management of trichotillomania with bimatoprost.
    Peabody T; Reitz S; Smith J; Teti B
    Optom Vis Sci; 2013 Jun; 90(6):e167-71. PubMed ID: 23645373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.
    Harii K; Arase S; Tsuboi R; Weng E; Daniels S; VanDenburgh A
    Aesthetic Plast Surg; 2014 Apr; 38(2):451-60. PubMed ID: 24643895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.